Betaxolol (systemic) vs Rifamycin Derivatives

Interacting Drugs
Betaxolol (systemic)
vs
Rifamycin Derivatives
Security Level
Minor, Monitor Therapy
Mechanism
Rifamycin Derivatives: May decrease the serum concentration of Beta-Blockers. Exceptions: Rifabutin.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Betaxolol (systemic) vs Rifamycin Derivatives